BMY 28100, a new oral cephalosporin.

BMY 28100, a new oral cephalosporin with a (Z)-propenyl side chain at the 3 position and a p-hydroxyphenylglycyl substituent at the 7 position, was evaluated in comparison with cefaclor and cephalexin and, when appropriate, ampicillin and vancomycin. In vitro, BMY 28100 was more active than the refe...

Full description

Saved in:
Bibliographic Details
Main Authors: Leitner, F, Pursiano, T A, Buck, R E, Tsai, Y H, Chisholm, D R, Misiek, M, Desiderio, J V, Kessler, R E
Format: Artigo
Language:Inglês
Published: 1987
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC174698/
https://ncbi.nlm.nih.gov/pubmed/3105449
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items